Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roflumilast add-on to fixed-dose LABA/ICS in COPD
2011-003606-24Phase 4Completed
- Sponsor
- Forest Research Institute, Inc
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Roflumilast add-on with Placebo add-on (2 arms). Primary endpoint: Rate of moderate or severe COPD exacerbations per subject per year. Started Dec 2011; status: completed.
02
Drugs
roflumilast
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2011-003606-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003606-24.